End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
15,780 CZK | -1.13% | -1.38% | +1.02% |
Mar. 26 | Philip Morris CR a.s. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 18 | Philip Morris CR a.s.(SEP:TABAK) dropped from FTSE All-World Index | CI |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- The company returns high margins, thereby supporting business profitability.
- This company will be of major interest to investors in search of a high dividend stock.
- The opinion of analysts covering the stock has improved over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past four months, analysts' average price target has been revised downwards significantly.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+1.02% | 1.76B | - | ||
+5.93% | 155B | B- | ||
+5.99% | 67.61B | B- | ||
+3.40% | 19.95B | A- | ||
+7.69% | 5.5B | B- | ||
+61.02% | 2.11B | - | C+ | |
-3.90% | 1.71B | - | D+ | |
-19.76% | 1.33B | - | B+ | |
0.00% | 656M | - | - | |
-15.61% | 454M | - | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
- Stock Market
- Equities
- TABAK Stock
- Ratings Philip Morris CR